Featured Research

from universities, journals, and other organizations

Wrist splints in children as effective as casts, study finds

Date:
September 8, 2010
Source:
Canadian Medical Association Journal
Summary:
In children with wrist fractures, a splint is as effective as a cast and provides greater comfort and easier hygiene, a new study finds.

In children with wrist fractures, a splint is as effective as a cast and provides greater comfort and easier hygiene, found a study published in CMAJ (Canadian Medical Association Journal).

Distal radius fractures -- wrist fractures -- are the most common break in children and a frequent reason for emergency department visits. The usual treatment is a short arm cast for four to six weeks with follow up visits to an orthopaedic surgeon.

The study, a randomized controlled trial with 92 children aged 5 to 12 years, included 43 children with distal radius fractures who were treated with splints and 49 in casts. Participants had acceptably angulated fractures (transverse or greenstick) of 15 degrees or less. The splint group was free to remove the splint to wash in the first four weeks, but otherwise, like the cast group, kept the splint on for the duration of therapy. After six weeks, the participants were assessed by a physiotherapist who did not know which treatment they had received.

"Our results support the growing body of evidence that promote splinting as a suitable alternative to casting for specific distal radius fractures," writes Dr. Kathy Boutis, Staff Physician and Associate Scientist at The Hospital for Sick Children (SickKids), and coauthors.

As well, patient and parental satisfaction with the splint was higher. Of the children with casts, 68% would have preferred to have the splint and only 12% of the splint group participants would have preferred the cast.

"There were no differences in maintaining fracture stability, complications, and the splint was shown to be superior in terms of family preferences," write the authors. "Inherent benefits of a pre-fabricated splint include easier hygiene, eliminating discomfort and anxiety associated with cast saw use, and easy application and removal. Thus, evidence from this research combined with the advantages of the splint advocate for this device in the treatment of these fracture cases."


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kathy Boutis, Andrew Willan, Paul Babyn, Ron Goeree, Andrew Howard. Cast versus splint in children with minimally angulated fractures of the distal radius: a randomized controlled trial. Canadian Medical Association Journal, 2010; DOI: 10.1503/cmaj.100119

Cite This Page:

Canadian Medical Association Journal. "Wrist splints in children as effective as casts, study finds." ScienceDaily. ScienceDaily, 8 September 2010. <www.sciencedaily.com/releases/2010/09/100907123733.htm>.
Canadian Medical Association Journal. (2010, September 8). Wrist splints in children as effective as casts, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/09/100907123733.htm
Canadian Medical Association Journal. "Wrist splints in children as effective as casts, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/09/100907123733.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins